The Vanguard Group 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 2:24 pm Purchase | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 13,219,759 9.570% | 3,992,875 (+43.27%) | Filing |
| 2024-11-12 1:26 pm Unchanged | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 9,226,884 7.840% | 0 (Unchanged) | Filing |
| 2024-11-04 10:22 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 9,226,884 7.840% | 5,183,705 (+128.21%) | Filing |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 4,043,179 5.460% | 572,553 (+16.50%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 3,470,626 5.220% | 3,470,626 (New Position) | Filing |